Eliglustat Tartrate Patent Expiration
Eliglustat Tartrate is used for long-term treatment of Gaucher disease type 1. It was first introduced by Genzyme Corp
Eliglustat Tartrate Patents
Given below is the list of patents protecting Eliglustat Tartrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cerdelga | US10888544 | Methods for treating Gaucher disease | Dec 13, 2038 | Genzyme Corp |
| Cerdelga | US10888547 | Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase | Jan 31, 2031 | Genzyme Corp |
| Cerdelga | US11458119 | Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase | Nov 24, 2030 | Genzyme Corp |
| Cerdelga | US7196205 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | Jun 26, 2026 | Genzyme Corp |
| Cerdelga | US6916802 | Amino ceramide-like compounds and therapeutic methods of use |
Apr 29, 2022
(Expired) | Genzyme Corp |
| Cerdelga | US7253185 | Amino ceramide-like compounds and therapeutic methods of use |
Apr 29, 2022
(Expired) | Genzyme Corp |
| Cerdelga | US7615573 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
Apr 29, 2022
(Expired) | Genzyme Corp |
Eliglustat Tartrate's Family Patents
Explore Our Curated Drug Screens
Eliglustat Tartrate Generic API Manufacturers
Several generic applications have been filed for Eliglustat Tartrate. The first generic version for Eliglustat Tartrate was by Aizant Drug Research Solutions Pvt Ltd and was approved on Sep 8, 2021. And the latest generic version is by Cipla Ltd and was approved on Dec 10, 2024.
Given below is the list of companies who have filed for Eliglustat Tartrate generic, along with the locations of their manufacturing plants worldwide.
1. AIZANT
Aizant Drug Research Solutions Pvt Ltd has filed for 1 generic for Eliglustat Tartrate. Given below are the details of the strengths of this generic introduced by Aizant.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 84MG BASE | capsule | Prescription | ORAL | AB | Sep 8, 2021 |
Manufacturing Plant Locations New
Aizant's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aizant as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
2. APOTEX
Apotex Inc has filed for 1 generic for Eliglustat Tartrate. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 84MG BASE | capsule | Discontinued | ORAL | N/A | Jul 10, 2024 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
3. CIPLA
Cipla Ltd has filed for 1 generic for Eliglustat Tartrate. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 84MG BASE | capsule | Prescription | ORAL | AB | Dec 10, 2024 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
4. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Eliglustat Tartrate. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 84MG BASE | capsule | Discontinued | ORAL | N/A | Aug 17, 2022 |
5. TEVA PHARMS USA INC
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Eliglustat Tartrate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 84MG BASE | capsule | Discontinued | ORAL | N/A | Dec 27, 2021 |
6. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 1 generic for Eliglustat Tartrate. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 84MG BASE | capsule | Prescription | ORAL | AB | May 2, 2023 |